Laser treatment of the prostate using the urolase fiber: The Dutch experience

Journal of Urology

Volumn 156, Issue 2, 1996, Pages 420-425

  Te Slaa, Ed ^a   Mooibroek, Jaap J ^a   De Reijke, Theo M ^a   Karthaus, Herbert F M ^a   Van Capelle, Jan Willem ^a   Gi, Norman Tjon Pian ^a   De La Rosette, Jean J M C H ^a  

^a NONE

Author keywords

Lasers; Prostatectomy; Prostatic hypertrophy; Urodynamics

Indexed keywords

EID: 1842531951     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65865-8     Document Type: Article

References (27)

1. Barry, M. J.: Epidemiology and natural history of benign prostatic hyperplasia. Urol. Clin. N. Amer., 17: 495, 1990.
2. Mebust, W. K., Holtgrewe, H. L., Cockett, A. T. K. and Peters, P. C.: Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J. Urol., 141: 243, 1989.
3. Lepor, H. for the Terazosin Research Group: Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia. Urology, 45: 406, 1995.
4. Stoner, E.: Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia. Urology, 43: 284, 1994.
5. de la Rosette, J. J., Tubaro, A., Höfner, K. and Carter, S. S.: Transurethral microwave thermotherapy: past, present and future. World J. Urol., 12: 352, 1994.
6. Lepor, H., Sypherd, D., Machi, G. and Derus, J.: Randomized double-blind study comparing the effectiveness of balloon dilation of the prostate and cystoscopy for the treatment of symptomatic benign prostatic hyperplasia. J. Urol., 147: 639, 1992.
7. Milroy, E. and Chapple, C. R.: The Urolume stent in the management of benign prostatic hyperplasia. J. Urol., part 2, 150: 1630, 1993.
8. Shanberg, A. M., Tansey, L. A. and Baghdassarian, R.: The use of the neodymium YAG laser in prostatectomy. J. Urol., part 2, 133: 196A, abstract 331, 1985.
9. Costello, A. J., Bowsher, W. G., Bolton, D. M., Braslis, K. G. and Burt, J.: Laser ablation of the prostate in patients with benign prostatic hypertrophy. Brit. J. Urol., 69: 603, 1992.
10. McCullough, D. L., Roth, R. A., Babayan, R. K., Gordon, J. O., Reese, J. H., Crawford, E. D., Fuselier, H. A., Smith, J. A., Murchison, R. J. and Kaye, K. W.: Transurethral ultrasound-guided laser-induced prostatectomy: national human cooperative study results. J. Urol., 150: 1607, 1993.
11. Kabalin, J. N.: Laser prostatectomy performed with a right angled firing neodymium:YAG laser fiber at 40 watts power setting. J. Urol., 150: 95, 1993.
12. Norris, J. P., Norris, D. M., Lee, R. D. and Rubenstein, M. A.: Visual laser ablation of the prostate: clinical experience in 108 patients. J. Urol., 150: 1612, 1993.
13. Leach, G. E., Sirls, L., Ganabathi, K., Roskamp, D. and Dmochowski, R.: Outpatient visual laser-assisted prostatectomy under local anesthesia. Urology, 43: 149, 1994.
14. de la Rosette, J. J., te Slaa, E., de Wildt, M. J. and Debruyne, F. M.: Experience with the Ultraline and Urolase laser fibers: is there any difference? World J. Urol., 13: 98, 1995.
15. Kabalin, J. N., Gill, H. S., Bite, G. and Wolfe, V.: Comparative study of laser versus electrocautery prostatic resection: 18-month followup with complex urodynamic assessment. J. Urol., 153: 94, 1995.
16. te Slaa, E., de Wildt, M. J. A. M., Rosier, P. F. W. M., Wijkstra, H., Debruyne, F. M. J. and de la Rosette, J. J. M. C. H.: Urodynamic assessment in the laser treatment of benign prostatic enlargement. Brit. J. Urol., 76: 604, 1995.
17. de Wildt, M. J. A. M., te Slaa, E., Rosier, P. F. W. M., Wijkstra, H., Debruyne, F. M. J. and de la Rosette, J. J. M. C. H.: Urodynamic results of laser treatment in patients with benign prostatic hyperplasia. Can outlet obstruction be relieved? J. Urol., 154: 174, 1995.
18. Bosch, J. L. H. R., Groen, J. and Schröder, F. H.: Treatment of benign prostatic hyperplasia by transurethral ultrasound-guided laser-induced prostatectomy (TULIP): effects on urodynamic parameters and symptoms. Urology, 44: 507, 1994.
19. Abrams, P. H. and Griffiths, D. J.: The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Brit. J. Urol., 51: 129, 1979.
20. Schäfer, W.: Principles and clinical application of advanced urodynamic analysis of voiding function. Urol. Clin. N. Amer., 17: 553, 1990.
21. Kabalin, J. N. and Gill, H. S.: Dosimetry studies utilizing the Urolase right angle firing neodymium:YAG laser fiber. Lasers Surg. Med., 14: 145, 1994.
22. Schulze, H.: Tulip: transurethral ultrasound-guided laser-induced prostatectomy. World J. Urol., 13: 94, 1995.
23. Buckley, J. F., Ligam, V. and Paterson, P. on behalf of the British ELAP group.: Endoscopic laser ablation of the prostate gland (ELAP). J. Urol., part 2, 151: 229A, abstract 5, 1994.
24. Costello, A. J. and Crowe, H. R.: A single institution experience of reflecting laser fibre prostatectomy over four years. J. Urol., part 2, 151: 229A, abstract 6, 1994.
25. Dixon, C. M.: A comparison of transurethral prostatectomy with visual laser ablation of the prostate using the Urolase right-angle fiber for the treatment of BPH. World J. Urol., 13: 126, 1995.
26. te Slaa, E., de Wildt, M. J. A. M., Debruyne, F. M. J., de Graaf, R. and de la Rosette, J. J. M. C. H.: Urinary tract infections following laser prostatectomy: is there a need for anti-biotic prophylaxis? Brit. J. Urol., 77: 220, 1990.
27. Orihuela, E., Motamedi, M., Pow-Sang, M., LaHaye, M., Cowan, D. F. and Warren, M. M.: Histopathological evaluation of laser thermocoagulation in the human prostate: optimization of laser irradiation for benign prostatic hyperplasia. J. Urol., 153: 1531, 1995.